Hydrogen sulfide-mediated cardioprotection: Mechanisms and therapeutic potential

Clinical Science

Volumn 120, Issue 6, 2011, Pages 219-229

  Lavu, Madhav ^a   Bhushan, Shashi ^a   Lefer, David J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardioprotection; Cardiovascular disease; Drug therapy; Hydrogen sulfide (H2S); Nitric oxide (NO)

Indexed keywords

ALLICIN; DIALLYL DISULFIDE; DIALLYL TRISULFIDE; DICLOFENAC; HYDROGEN SULFIDE; NITRIC OXIDE; SULFUR;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CLINICAL TRIAL (TOPIC); DRUG MECHANISM; DRUG METABOLISM; GARLIC; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TREATMENT INDICATION; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS;

EID: 79251606051     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100462     Document Type: Review

References (151)

1. Kump, L., Pavlov, A. and Arthur, M. (2005) Massive release of hydrogen sulfide to the surface ocean and atmosphere during intervals of oceanic anoxia. Geology 33, 397-400
2. Ward, P. (2008) If almost every species on Earth was killed some 250 million years ago, how did our ancient ancestors survive and evolve into us? (http://seedmagazine.com/content/article/suspending-life)
3. Zetter, K. (2008) Hydrogen sulfide may kill us, bring us back to life (http://www.wired.com/science/planetearth/news/2008/03/peter-ward-qa? currentPage=all)
4. Townsend, R. (2009) The Development of Life on Earth (http://www.astro. wisc.edu/~townsend/static.php?ref= diploma-4)
5. Van Dover, C. L., German, C. R., Speer, K. G., Parson, L. M. and Vrijenhoek, R. C. (2002) Evolution and biogeography of deep-sea vent and seep invertebrates. Science 295, 1253-1257
6. Knight, J. D. (2010) Deep sea hydrothermal vents (http://www.seasky.org/ deep-sea/hydrothermalvents.html)
7. Goubern, M., Andriamihaja, M., Nubel, T., Blachier, F. and Bouillaud, F. (2007) Sulfide, the first inorganic substrate for human cells. FASEB J. 21, 1699-1706
8. 2S induces a suspended animation-like state in mice. Science 308, 518
9. Roth, M. B. and Nystul, T. (2005) Buying time in suspended animation. Sci. Am. 292, 48-55
10. Kamoun, P. (2004) Endogenous production of hydrogen sulfide in mammals. Amino Acids 26, 243-254
11. Kimura, H. (2010) Hydrogen sulfide: from brain to gut. Antioxid. Redox Signaling 12, 1111-1123
12. Li, L., Hsu, A. and Moore, P. K. (2009) Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation: a tale of three gases!. Pharmacol. Ther. 123, 386-400
13. Abe, K. and Kimura, H. (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 16, 1066-1071 (Pubitemid 26140863)
14. Kabil, O. and Banerjee, R. (2010) Redox biochemistry of hydrogen sulfide. J. Biol. Chem. 285, 21903-21907
15. Kimura, H. (2010) Hydrogen sulfide: its production, release and functions. Amino Acids, doi 10. 1007/s00726-010-0510-x
16. Shibuya, N., Mikami, Y., Kimura, Y., Nagahara, N. and Kimura, H. (2009) Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. (Tokyo) 146, 623-626
17. Shibuya, N., Tanaka, M., Yoshida, M., Ogasawara, Y., Togawa, T., Ishii, K. and Kimura, H. (2009) 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid. Redox Signaling 11, 703-714
18. Dombkowski, R. A., Russell, M. J. and Olson, K. R. (2004) Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R678-R685
19. Webb, G. D., Lim, L. H., Oh, V. M., Yeo, S. B., Cheong, Y. P., Ali, M. Y., El Oakley, R., Lee, C. N., Wong, P. S., Caleb, M. G. et al. (2008) Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J. Pharmacol. Exp. Ther. 324, 876-882
20. Whiteman, M. and Moore, P. K. (2009) Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J. Cell. Mol. Med. 13, 488-507
21. Ishigami, M., Hiraki, K., Umemura, K., Ogasawara, Y., Ishii, K. and Kimura, H. (2009) A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid. Redox Signaling 11, 205-214
22. Toohey, J. I. (1989) Sulphane sulphur in biological systems: a possible regulatory role. Biochem. J. 264, 625-632
23. Ogasawara, Y., Isoda, S. and Tanabe, S. (1994) Tissue and subcellular distribution of bound and acid-labile sulfur, and the enzymic capacity for sulfide production in the rat. Biol. Pharm. Bull. 17, 1535-1542
24. 2S in rat tissues. Can. J. Physiol. Pharmacol. 81, 848-853
25. Geng, B., Yang, J., Qi, Y., Zhao, J., Pang, Y., Du, J. and Tang, C. (2004) H2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun. 313, 362-368
26. Doeller, J. E., Isbell, T. S., Benavides, G., Koenitzer, J., Patel, H., Patel, R. P., Lancaster, Jr, J. R., Darley-Usmar, V. M. and Kraus, D. W. (2005) Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal. Biochem. 341, 40-51
27. 2S in the gastrointestinal tract: still in search of a physiologic function. Antioxid. Redox Signaling 12, 1135-1146
28. Ratnam, S., Maclean, K. N., Jacobs, R. L., Brosnan, M. E., Kraus, J. P. and Brosnan, J. T. (2002) Hormonal regulation of cystathionine β-synthase expression in liver. J. Biol. Chem. 277, 42912-42918
29. Puranik, M., Weeks, C. L., Lahaye, D., Kabil, O., Taoka, S., Nielsen, S. B., Groves, J. T., Banerjee, R. and Spiro, T. G. (2006) Dynamics of carbon monoxide binding to cystathionine β-synthase. J. Biol. Chem. 281, 13433-13438
30. Li, X., Bazer, F. W., Gao, H., Jobgen, W., Johnson, G. A., Li, P., McKnight, J. R., Satterfield, M. C., Spencer, T. E. and Wu, G. (2009) Amino acids and gaseous signaling. Amino Acids 37, 65-78
31. 2S). Cell. Biochem. Funct. 28, 95-106
32. 2S): the third gas of interest for pharmacologists. Pharmacol. Rep. 59, 4-24
33. Belardinelli, M. C., Chabli, A., Chadefaux-Vekemans, B. and Kamoun, P. (2001) Urinary sulfur compounds in Down syndrome. Clin. Chem. 47, 1500-1501
34. Furne, J., Springfield, J., Koenig, T., DeMaster, E. and Levitt, M. D. (2001) Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa. Biochem. Pharmacol. 62, 255-259
35. Beauchamp, Jr, R. O., Bus, J. S., Popp, J. A., Boreiko, C. J. and Andjelkovich, D. A. (1984) A critical review of the literature on hydrogen sulfide toxicity. Crit. Rev. Toxicol. 13, 25-97
36. Qu, K., Lee, S. W., Bian, J. S., Low, C. M. and Wong, P. T. (2008) Hydrogen sulfide: neurochemistry and neurobiology. Neurochem. Int. 52, 155-165
37. Szabo, C. (2007) Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discovery 6, 917-935
38. Olson, K. R. (2009) Is hydrogen sulfide a circulating 'gasotransmitter' in vertebrate blood? Biochim. Biophys. Acta 1787, 856-863
39. Hosoki, R., Matsuki, N. and Kimura, H. (1997) The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem. Biophys. Res. Commun. 237, 527-531
40. ATP channel opener. EMBO J. 20, 6008-6016
41. Ali, M. Y., Ping, C. Y., Mok, Y. Y., Ling, L., Whiteman, M., Bhatia, M. and Moore, P. K. (2006) Regulation of vascular nitric oxide in vitro and in vivo: a new role for endogenous hydrogen sulphide? Br. J. Pharmacol. 149, 625-634
42. Cheng, Y., Ndisang, J. F., Tang, G., Cao, K. and Wang, R. (2004) Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am. J. Physiol. Heart Circ. Physiol. 287, H2316-H2323
43. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 42, 539-548
44. Kiss, L., Deitch, E. A. and Szabo, C. (2008) Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci. 83, 589-594
45. Lee, S.W., Cheng, Y., Moore, P. K. and Bian, J. S. (2007) Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 358, 1142-1147
46. Wang, Y. F., Mainali, P., Tang, C. S., Shi, L., Zhang, C. Y., Yan, H., Liu, X. Q. and Du, J. B. (2008) Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats. Chin. Med. J. 121, 420-423
47. Srilatha, B., Adaikan, P. G., Li, L. and Moore, P. K. (2007) Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function. J. Sex. Med. 4, 1304-1311
48. 2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart Circ. Physiol. 283, H474-H480
49. Johansen, D., Ytrehus, K. and Baxter, G. F. (2006) Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury: evidence for a role of K ATP channels. Basic Res. Cardiol. 101, 53-60
50. Lim, J. J., Liu, Y. H., Khin, E. S. and Bian, J. S. (2008) Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 295, C1261-C1270
51. Kubo, S., Kajiwara, M. and Kawabata, A. (2007) Dual modulation of the tension of isolated gastric artery and gastric mucosal circulation by hydrogen sulfide in rats. Inflammopharmacology 15, 288-292 (Pubitemid 351196139)
52. 2-dependent manner. Am. J. Physiol. Heart Circ. Physiol. 292, H1953-H1960
53. Predmore, B. L., Alendy, M. J., Ahmed, K. I., Leeuwenburgh, C. and Julian, D. (2010) The hydrogen sulfide signaling system: changes during aging and the benefits of caloric restriction. Age (Dodr) 32, 467-481
54. Dombkowski, R. A., Russell, M. J., Schulman, A. A., Doellman, M. M. and Olson, K. R. (2005) Vertebrate phylogeny of hydrogen sulfide vasoactivity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R243-R252
55. Olson, K. R., Forgan, L. G., Dombkowski, R. A. and Forster, M. E. (2008) Oxygen dependency of hydrogen sulfide-mediated vasoconstriction in cyclostome aortas. J. Exp. Biol. 211, 2205-2213
56. Ufnal, M., Sikora, M. and Dudek, M. (2008) Exogenous hydrogen sulfide produces hemodynamic effects by triggering central neuroregulatory mechanisms. Acta Neurobiol. Exp. 68, 382-388
57. + channel-dependent decrease in blood pressure in freely moving rats. Neuroscience 152, 169-177
58. Yan, H., Du, J. and Tang, C. (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem. Biophys. Res. Commun. 313, 22-27
59. Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A. K., Mu, W., Zhang, S. et al. (2008) H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ -lyase. Science 322, 587-590
60. Mok, Y. Y., Atan, M. S., Yoke Ping, C., Zhong Jing,W., Bhatia, M., Moochhala, S. and Moore, P. K. (2004) Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br. J. Pharmacol. 143, 881-889
61. Li, L., Bhatia, M., Zhu, Y. Z., Zhu, Y. C., Ramnath, R. D., Wang, Z. J., Anuar, F. B., Whiteman, M., Salto-Tellez, M. and Moore, P. K. (2005) Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 19, 1196-1198
62. Whiteman, M., Li, L., Kostetski, I., Chu, S. H., Siau, J. L., Bhatia, M. and Moore, P. K. (2006) Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun. 343, 303-310
63. Liu, Y. H. and Bian, J. S. (2010) Bicarbonate-dependent effect of hydrogen sulfide on vascular contractility in rat aortic rings. Am. J. Physiol. Cell Physiol. 299, C866-C872
64. Geng, B., Cui, Y., Zhao, J., Yu, F., Zhu, Y., Xu, G., Zhang, Z., Tang, C. and Du, J. (2007) Hydrogen sulfide downregulates the aortic l-arginine/nitric oxide pathway in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1608-R1618
65. Kubo, S., Kurokawa, Y., Doe, I., Masuko, T., Sekiguchi, F. and Kawabata, A. (2007) Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology 241, 92-97
66. Zhong, G., Chen, F., Cheng, Y., Tang, C. and Du, J. (2003) The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J. Hypertens. 21, 1879-1885
67. 2S) and nitric oxide (NO) in vasorelaxation induced by stonustoxin (SNTX), a lethal and hypotensive protein factor isolated from stonefish Synanceja horrida venom. Life Sci. 80, 1664-1668
68. Muzaffar, S., Shukla, N., Bond, M., Newby, A. C., Angelini, G. D., Sparatore, A., Del Soldato, P. and Jeremy, J. Y. (2008) Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells. J. Vasc. Res. 45, 521-528
69. Sun, Y. G., Cao, Y. X., Wang, W.W., Ma, S. F., Yao, T. and Zhu, Y. C. (2008) Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc. Res. 79, 632-641
70. Cai,W. J., Wang,M. J., Moore, P.K., Jin, H. M., Yao, T. and Zhu, Y. C. (2007) The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc. Res. 76, 29-40
71. Tang, G., Wu, L., Liang, W. and Wang, R. (2005) Direct stimulation of KATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol. Pharmacol. 68, 1757-1764
72. Laggner, H., Muellner, M. K., Schreier, S., Sturm, B., Hermann, M., Exner, M., Gmeiner, B. M. and Kapiotis, S. (2007) Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radical Res. 41, 741-747
73. Collin, M., Anuar, F. B., Murch, O., Bhatia, M., Moore, P. K. and Thiemermann, C. (2005) Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br. J. Pharmacol. 146, 498-505
74. Zhang, H., Zhi, L., Moore, P. K. and Bhatia, M. (2006) Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L1193-L1201
75. Miles, E. W. and Kraus, J. P. (2004) Cystathionine β-synthase: structure, function, regulation, and location of homocystinuria-causing mutations. J. Biol. Chem. 279, 29871-29874
76. Ishii, I., Akahoshi, N., Yu, X. N., Kobayashi, Y., Namekata, K., Komaki, G. and Kimura, H. (2004) Murine cystathionine γ -lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. Biochem. J. 381, 113-123
77. 2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 25, 951-954
78. 2S) in hypertensive rats. Zhonghua Er Ke Za Zhi 42, 172-175
79. 2S) bioavailability in diabetes. Br. J. Pharmacol. 155, 617-619
80. 2S is impaired in non-obese diabetic (NOD) mice. Br. J. Pharmacol. 155, 673-680
81. Xiaohui, L., Junbao, D., Lin, S., Jian, L., Xiuying, T., Jianguang, Q., Bing, W., Hongfang, J. and Chaoshu, T. (2005) Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ. J. 69, 1418-1424
82. Chunyu, Z., Junbao, D., Dingfang, B., Hui, Y., Xiuying, T. and Chaoshu, T. (2003) The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem. Biophys. Res. Commun. 302, 810-816
83. Yanfei, W., Lin, S., Junbao, D. and Chaoshu, T. (2006) Impact of L-arginine on hydrogen sulfide/cystathionine-γ -lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem. Biophys. Res. Commun. 345, 851-857
84. Li, X. H., Du, J. B. and Tang, C. S. (2006) Impact of hydrogen sulfide donor on pulmonary vascular structure and vasoactive peptides in rats with pulmonary hypertension induced by high pulmonary blood flow. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28, 159-163
85. Mitsuhashi, H., Yamashita, S., Ikeuchi, H., Kuroiwa, T., Kaneko, Y., Hiromura, K., Ueki, K. and Nojima, Y. (2005) Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 24, 529-534 (Pubitemid 43755999)
86. Zhang, H. and Bhatia, M. (2008) Hydrogen sulfide: a novel mediator of leukocyte activation. Immunopharmacol. Immunotoxicol. 30, 631-645
87. Zanardo, R. C., Brancaleone, V., Distrutti, E., Fiorucci, S., Cirino, G. and Wallace, J. L. (2006) Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 20, 2118-2120
88. Rinaldi, L., Gobbi, G., Pambianco, M., Micheloni, C., Mirandola, P. and Vitale, M. (2006) Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3. Lab. Invest. 86, 391-397
89. Oh, G. S., Pae, H. O., Lee, B. S., Kim, B. N., Kim, J. M., Kim, H. R., Jeon, S. B., Jeon, W. K., Chae, H. J. and Chung, H. T. (2006) Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264. 7 macrophages stimulated with lipopolysaccharide. Free Radical Biol. Med. 41, 106-119
90. Yan, S. K., Chang, T., Wang, H., Wu, L., Wang, R. and Meng, Q. H. (2006) Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 351, 485-491
91. Whiteman, M., Armstrong, J. S., Chu, S. H., Jia-Ling, S., Wong, B. S., Cheung, N. S., Halliwell, B. and Moore, P. K. (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J. Neurochem. 90, 765-768
92. Tang, X. Q., Yang, C. T., Chen, J., Yin, W. L., Tian, S.W., Hu, B., Feng, J. Q. and Li, Y. J. (2008) Effect of hydrogen sulphide on β-amyloid- induced damage in PC12 cells. Clin. Exp. Pharmacol. Physiol. 35, 180-186
93. Whiteman, M., Cheung, N. S., Zhu, Y. Z., Chu, S. H., Siau, J. L., Wong, B. S., Armstrong, J. S. and Moore, P. K. (2005) Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain? Biochem. Biophys. Res. Commun. 326, 794-798
94. Zagli, G., Patacchini, R., Trevisani, M., Abbate, R., Cinotti, S., Gensini, G. F., Masotti, G. and Geppetti, P. (2007) Hydrogen sulfide inhibits human platelet aggregation. Eur. J. Pharmacol. 559, 65-68
95. Du, J., Hui, Y., Cheung, Y., Bin, G., Jiang, H., Chen, X. and Tang, C. (2004) The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 19, 75-80 (Pubitemid 38489034)
96. Meng, Q. H., Yang, G., Yang, W., Jiang, B., Wu, L. and Wang, R. (2007) Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am. J. Pathol. 170, 1406-1414
97. Shi, Y. X., Chen, Y., Zhu, Y. Z., Huang, G. Y., Moore, P. K., Huang, S. H., Yao, T. and Zhu, Y. C. (2007) Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 293, H2093-H2100
98. 2S). Free Radical Biol. Med. 46, 616-623
99. Nicholson, C. K. and Calvert, J.W. (2010) Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol. Res. 62, 289-297
100. Sivarajah, A., McDonald, M. C. and Thiemermann, C. (2006) The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 26, 154-161
101. Geng, B., Chang, L., Pan, C., Qi, Y., Zhao, J., Pang, Y., Du, J. and Tang, C. (2004) Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem. Biophys. Res. Commun. 318, 756-763
102. ATP channels. Can. J. Physiol. Pharmacol. 85, 1248-1253
103. Sivarajah, A., Collino, M., Yasin, M., Benetti, E., Gallicchio, M., Mazzon, E., Cuzzocrea, S., Fantozzi, R. and Thiemermann, C. (2009) Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31, 267-274
104. Ji, Y., Pang, Q. F., Xu, G.,Wang, L.,Wang, J. K. and Zeng, Y. M. (2008) Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur. J. Pharmacol. 587, 1-7
105. Jha, S., Calvert, J. W., Duranski, M. R., Ramachandran, A. and Lefer, D. J. (2008) Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling. Am. J. Physiol. Heart Circ. Physiol. 295, H801-H806
106. Osipov, R. M., Robich, M. P., Feng, J., Liu, Y., Clements, R. T., Glazer, H. P., Sodha, N. R., Szabo, C., Bianchi, C. and Sellke, F. W. (2009) Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J. Cardiovasc. Pharmacol. 54, 287-297
107. Sodha, N. R., Clements, R. T., Feng, J., Liu, Y., Bianchi, C., Horvath, E. M., Szabo, C. and Sellke, F.W. (2008) The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury. Eur. J. Cardiothorac. Surg. 33, 906-913
108. Calvert, J. W., Elston, M., Nicholson, C. K., Gundewar, S., Jha, S., Elrod, J.W., Ramachandran, A. and Lefer, D. J. (2010) Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 122, 11-19
109. Yong, Q. C., Lee, S. W., Foo, C. S., Neo, K. L., Chen, X. and Bian, J. S. (2008) Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am. J. Physiol. Heart Circ. Physiol. 295, H1330-H40
110. Elrod, J.W., Calvert, J.W., Morrison, J., Doeller, J. E., Kraus, D.W., Tao, L., Jiao, X., Scalia, R., Kiss, L., Szabo, C. et al. (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc. Natl. Acad. Sci. U.S.A. 104, 15560-15565
111. Forgan, L. G. and Forster, M. E. (2010) Oxygen consumption, ventilation frequency and cytochrome c oxidase activity in blue cod (Parapercis colias) exposed to hydrogen sulphide or isoeugenol. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 151, 57-65
112. Cooper, C. E. and Brown, G. C. (2008) The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J. Bioenerg. Biomembr. 40, 533-539
113. Volpato, G. P., Searles, R., Yu, B., Scherrer-Crosbie, M., Bloch, K. D., Ichinose, F. and Zapol,W. M. (2008) Inhaled hydrogen sulfide: a rapidly reversible inhibitor of cardiac and metabolic function in the mouse. Anesthesiology 108, 659-668
114. Lefer, D. J. (2007) A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc. Natl. Acad. Sci. U.S.A. 104, 17907-17908
115. Yong, Q. C., Pan, T. T., Hu, L. F. and Bian, J. S. (2008) Negative regulation of β-adrenergic function by hydrogen sulphide in the rat hearts. J. Mol. Cell. Cardiol. 44, 701-710
116. Yong, Q. C., Choo, C. H., Tan, B. H., Low, C. M. and Bian, J. S. (2010) Effect of hydrogen sulfide on intracellular calcium homeostasis in neuronal cells. Neurochem. Int. 56, 508-515
117. Bian, J. S., Yong, Q. C., Pan, T. T., Feng, Z. N., Ali, M. Y., Zhou, S. andMoore, P. K. (2006) Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J. Pharmacol. Exp. Ther. 316, 670-678
118. Zhu, Y. Z., Wang, Z. J., Ho, P., Loke, Y. Y., Zhu, Y. C., Huang, S. H., Tan, C. S., Whiteman, M., Lu, J. and Moore, P. K. (2007) Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J. Appl. Physiol. 102, 261-268
119. 2S protects myocardium against ischemia/reperfusion injury and its effect on c-Fos protein expression in rats. Sheng Li Xue Bao 60, 221-227
120. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am. J. Physiol. Cell Physiol. 294, C169-C177
121. Calvert, J.W., Jha, S., Gundewar, S., Elrod, J.W., Ramachandran, A., Pattillo, C. B., Kevil, C. G. and Lefer, D. J. (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ. Res. 105, 365-374
122. Hu, Y., Chen, X., Pan, T. T., Neo, K. L., Lee, S.W., Khin, E. S., Moore, P. K. and Bian, J. S. (2008) Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Pflugers Arch. 455, 607-616
123. Su, Y. W., Liang,C., Jin, H. F., Tang, X. Y.,Han,W., Chai, L. J., Zhang, C. Y., Geng, B., Tang, C. S. and Du, J. B. (2009) Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circ. J. 73, 741-749
124. Osipov, R.M., Robich,M. P., Feng, J., Chan, V., Clements, R. T., Deyo, R. J., Szabo, C. and Sellke, F.W. (2010) Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interact. Cardiovasc. Thorac. Surg. 10, 506-512
125. Minamishima, S., Bougaki, M., Sips, P. Y., Yu, J. D., Minamishima, Y. A., Elrod, J.W., Lefer, D. J., Bloch, K. D. and Ichinose, F. (2009) Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120, 888-896
126. Zunnunov, Z. R. (2010) Potentiation of anti-ischemic and anti-anginal action of nitrates by hydrogen sulfide balneotherapy in patients with angina of effort. Vopr. Kurortol. Fizioter. Lech. Fiz. Kult Jan-Feb, 11-14
127. Zhang, D., Jiang, X., Fang, P., Yan, Y., Song, J., Gupta, S., Schafer, A. I., Durante, W., Kruger, W. D., Yang, X. and Wang, H. (2009) Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine β-synthase-deficient mice. Circulation 120, 1893-1902
128. 2S) and NMDA-receptor in heart failure. Indian J. Biochem. Biophys. 46, 441-446
129. Chang, L., Geng, B., Yu, F., Zhao, J., Jiang, H., Du, J. and Tang, C. (2008) Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34, 573-585
130. 2S on human aorta smooth muscle cells. FASEB J. 20, 553-555
131. Predmore, B. L. and Lefer, D. J. (2010) Development of hydrogen sulfide-based therapeutics for cardiovascular disease. J. Cardiovasc. Transl. Res. 3, 487-498
132. Reference deleted
133. Li, L., Rossoni, G., Sparatore, A., Lee, L. C., Del Soldato, P. and Moore, P. K. (2007) Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radical Biol. Med. 42, 706-719
134. Rossoni, G., Sparatore, A., Tazzari, V., Manfredi, B., Del Soldato, P. and Berti, F. (2008) The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart. Br. J. Pharmacol. 153, 100-109
135. Sidhapuriwala, J., Li, L., Sparatore, A., Bhatia, M. and Moore, P. K. (2007) Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative, on carrageenan-induced hindpaw oedema formation in the rat. Eur. J. Pharmacol. 569, 149-154
136. Baskar, R., Sparatore, A., Del Soldato, P. and Moore, P. K. (2008) Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur. J. Pharmacol. 594, 1-8
137. Li, L., Whiteman, M., Guan, Y. Y., Neo, K. L., Cheng, Y., Lee, S. W., Zhao, Y., Baskar, R., Tan, C. H. and Moore, P. K. (2008) Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117, 2351-2360
138. Wallace, J. L., Dicay, M., McKnight, W. and Martin, G. R. (2007) Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 21, 4070-4076
139. 2S-releasing NSAIDs: what lies beyond the horizon. Dig. Liver Dis. 39, 1043-1051
140. 2S-releasing aspirin. Free Radical Biol.Med. 46, 586-592
141. Wallace, J. L., Caliendo, G., Santagada, V. and Cirino, G. (2010) Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). Br. J. Pharmacol. 159, 1236-1246
142. Li, S., Sang, S., Pan, M. H., Lai, C. S., Lo, C. Y., Yang, C. S. and Ho, C. T. (2007) Anti-inflammatory property of the urinary metabolites of nobiletin in mouse. Bioorg. Med. Chem. Lett. 17, 5177-5181
143. 2S-releasing aspirin. Free Radical Biol. Med. 48, 1263-1272
144. Benavides, G. A., Squadrito, G. L., Mills, R. W., Patel, H. D., Isbell, T. S., Patel, R. P., Darley-Usmar, V. M., Doeller, J. E. and Kraus, D.W. (2007) Hydrogen sulfide mediates the vasoactivity of garlic. Proc. Natl. Acad. Sci. U.S.A. 104, 17977-17982
145. Lei, Y. P., Liu, C. T., Sheen, L. Y., Chen, H. W. and Lii, C. K. (2010) Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein. Mol. Nutr. Food Res. 54 (Suppl. 1), S42-S52
146. Predmore, B. L., Grinsfelder, D. B., Aragon, J. P., Elston, M., Calvert, J.W. and Lefer, D. J. (2010) The stable hydrogen sulfide donor, diallyl trisulfide, protects against acute myocardial infarction in mice. J. Am. Coll. Cardiol. 55 (Suppl. 10A), A116.E1089
147. Rai, S. K., Sharma, M. and Tiwari, M. (2009) Inhibitory effect of novel diallyldisulfide analogs on HMG-CoA reductase expression in hypercholesterolemic rats: CREB as a potential upstream target. Life Sci. 85, 211-219
148. Chuah, S. C., Moore, P. K. and Zhu, Y. Z. (2007) S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am. J. Physiol. Heart Circ. Physiol. 293, H2693-H2701
149. Wang, Q., Liu, H. R., Mu, Q., Rose, P. and Zhu, Y. Z. (2009) S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol. 54, 139-146
150. 2S production. Antioxid. Redox Signaling 12, 1155-1165
151. Shukla, N., Rossoni, G., Hotston, M., Sparatore, A., Del Soldato, P., Tazzari, V., Tazzari, V., Persad, R., Angelini, G. D. and Jeremy, J. Y. (2009) Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats. BJU Int. 103, 1522-1529